Comprehensive and Safe Decongestion in Acutely Decompensated Heart Failure.


Journal

Current heart failure reports
ISSN: 1546-9549
Titre abrégé: Curr Heart Fail Rep
Pays: United States
ID NLM: 101196487

Informations de publication

Date de publication:
10 2022
Historique:
accepted: 28 07 2022
pubmed: 1 9 2022
medline: 12 10 2022
entrez: 31 8 2022
Statut: ppublish

Résumé

Progressive intravascular, interstitial, and alveolar fluid overload underlies the transition from compensated to acutely decompensated heart failure and loop diuretics are the mainstay of treatment. Adverse effects and resistance to loop diuretics received much attention while the contribution of a depressed cardiac output to diuretic resistance was downplayed. Analysis of experience with positive inotropic agents, especially dobutamine, indicates that enhancement of cardiac output is not consistently associated with increased renal blood flow. However, urinary output and renal sodium excretion increase likely due to dobutamine-mediated decrease in renal and systemic reduced activation of sympathetic nervous- and renin-angiotensin-aldosterone system. Mechanical circulatory support with left ventricular assist devices ascertained the contribution of low cardiac output to diuretic resistance and the pathogenesis and progression of kidney disease in acutely decompensated heart failure. Diuretic resistance commonly occurs in acutely decompensated heart failure. However, failure to resolve fluid overload despite high doses of loop diuretics should alert to the presence of a low cardiac output state.

Identifiants

pubmed: 36045314
doi: 10.1007/s11897-022-00573-y
pii: 10.1007/s11897-022-00573-y
doi:

Substances chimiques

Diuretics 0
Sodium Potassium Chloride Symporter Inhibitors 0
Dobutamine 3S12J47372
Sodium 9NEZ333N27

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

364-374

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Auteurs

Jason Stencel (J)

Tulane University School of Medicine, New Orleans, LA, USA. jstencel@tulane.edu.

Indranee Rajapreyar (I)

Thomas Jefferson University Hospitals, Philadelphia, PA, USA.

Rohan Samson (R)

Rudd Heart and Lung Center, University of Louisville Health, Louisville, KY, USA.

Thierry Le Jemtel (T)

Tulane University School of Medicine, New Orleans, LA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH